ClinicalTrials.Veeva
Menu

Find clinical trials for Acute Myeloid Leukemia (AML) in Cincinnati, OH

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Acute Myeloid Leukemia
Leukemia
Myeloid Leukemia
Myelodysplastic Syndromes
Preleukemia
Chronic Myelomonocytic Leukemia
Syndrome

Acute Myeloid Leukemia (AML) trials near Cincinnati, OH, USA:

CLN-049 in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)

CLN-049-001 is a Phase 1, open-label, multicenter, first-in-human trial of CLN-049 in patients with Relapsed/Refractory Acute Myeloid...

Enrolling
Relapsed/Refractory Acute Myeloid Leukemia (AML)
Myelodysplastic Syndrome (MDS)
Drug: CLN-049

Phase 1

Cullinan Therapeutics Inc.

Cincinnati, Ohio, United States and 6 other locations

study of five dose levels of APVO436 in combination with venetoclax and azacitidine (ven/aza) in adult patients with newly diagnosed, CD123+ AML...

Enrolling
Acute Myeloid Leukemia (AML)
Drug: Venetoclax
Drug: Azacitidine

Phase 1

Aptevo Therapeutics

Cincinnati,, Ohio, United States and 6 other locations

or young adults with a certain kind of blood cancer (FLT3-ITD AML) might be able to join this study if it has come back after remission or i...

Active, not recruiting
Acute Myeloid Leukemia
Drug: Quizartinib
Drug: Cytarabine

Phase 1, Phase 2

Daiichi Sankyo
Daiichi Sankyo

Cincinnati, Ohio, United States and 26 other locations

Eligible untreated patients with FLT3 acute myeloid leukemia (AML) between the ages of 18 and 70 will be randomiz...

Active, not recruiting
Acute Myeloid Leukemia
Drug: Gilteritinib
Drug: Daunorubicin

Phase 2

PrECOG

Cincinnati, Ohio, United States and 43 other locations

Refractory Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML), or Acute Myeloid Leukemia (AML...

Active, not recruiting
Relapsed Adult AML
AML/MDS
Drug: LP-108 and azacitidine
Drug: LP-108

Phase 1

Newave Pharmaceutical

Cincinnati, Ohio, United States and 6 other locations

inhibitor of MDM2 for the treatment of adults with FLT3 mutated Acute Myeloid Leukemia. Participants must be relapsed/refr...

Active, not recruiting
Acute Myeloid Leukemia
Drug: TL-895
Drug: KRT-232

Phase 1, Phase 2

Telios Pharma

Cincinnati, Ohio, United States and 34 other locations

This is a multi-center, randomized, double-blinded, placebo controlled trial.

Enrolling
Adult Acute Myeloid Leukemia
Drug: mocravimod

Phase 3

Priothera

Cincinnati, Ohio, United States and 104 other locations

combination with chemotherapy in participants with newly diagnosed FMS-like tyrosine kinase 3 (FLT3)-internal tandem duplication (ITD) negative acute...

Enrolling
Leukemia
Drug: Quizartinib
Drug: Placebo

Phase 3

Daiichi Sankyo
Daiichi Sankyo

Cincinnati, Ohio, United States and 277 other locations

safe and if they have beneficial effects in treating patients with acute myeloid leukemia (AML) or acute ...

Enrolling
Acute Leukemia of Ambiguous Lineage
Refractory Acute Myeloid Leukemia
Drug: Revumenib
Drug: Methotrexate

Phase 1

St. Jude Children's Research Hospital
St. Jude Children's Research Hospital

Cincinnati, Ohio, United States and 5 other locations

with fludarabine and cytarabine in treating patients with acute myeloid leukemia (AML), myelodysplastic syndrome ...

Enrolling
Refractory Juvenile Myelomonocytic Leukemia
Refractory Childhood Acute Myeloid Leukemia
Drug: Cytarabine
Procedure: Echocardiography Test

Phase 1

Children's Oncology Group

Cincinnati, Ohio, United States and 17 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems